1345: Shanghai Pioneer Holding Ltd - Summary | Jitta

Shanghai Pioneer Holding Ltd

HKG:1345

Price
HK$2.49
Loss Chance
47.8%
5.49JITTA SCORE
56.10%Over Jitta Line
Jitta Ranking
43 / 190
332 / 2,342
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (55)
Recent Business Performance (75)
Financial Strength (81)
Return to Shareholders (57)
Competitive Advantage (59)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Share RepurchaseEvery Year
Interest Coverage RatioVery Good
Revenue and EarningRevenue decline from 2017-2022
Operating MarginInconsistent
Key Stats
Jitta Score
Jitta Line
5.49
56.10%
3.66
696.35%
Health Care Distributors
4.88
37.01%
6.68
72.35%
4.44
44.84%
COMPANY DESCRIPTION
Shanghai Pioneer Holding Ltd, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People’s Republic of China. It has a portfolio of pharmaceutical products, such as ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas, as well as medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company sells its products to hospitals and medical institutions, and pharmacies. In addition, it engages in sale of ancillary tools and dental devices, and imported in-licensed prescription products; research and develops denture and implants dentistry; and provides metal finishing services. The company was formerly known as China Pioneer Pharma Holdings Limited. Shanghai Pioneer Holding Ltd was founded in 1996 and is headquartered in Shanghai, the People’s Republic of China. Shanghai Pioneer Holding Ltd is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.